You just read:

Forty Seven, Inc. to Present Clinical Data on 5F9, its First-in-Class CD47 Antibody, at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

Forty Seven, Inc.

May 16, 2018, 17:01 ET